46 studies found for:    Open Studies | "Myositis"
Show Display Options
Rank Status Study
21 Recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide
22 Recruiting The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis
Condition: Juvenile Dermatomyositis
Interventions: Dietary Supplement: Creapure;   Dietary Supplement: Glucose Tablet
23 Recruiting Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD
Condition: Facioscapulohumeral Muscular Dystrophy 1a
Intervention: Other: No intervention, observational
24 Recruiting In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Intervention: Drug: Palovarotene
25 Recruiting An Open-Label Extension Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Interventions: Drug: Palovarotene dose level 1;   Drug: Palovarotene dose level 2;   Drug: Palovarotene dose level 3
26 Not yet recruiting Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)
Condition: Dermatomyositis
Interventions: Drug: Octagam 10%;   Other: Placebo
27 Recruiting The Fibrodysplasia Ossificans Progressiva (FOP) Connection Registry
Condition: Fibrodysplasia Ossificans Progressiva (FOP)
Intervention:
28 Recruiting A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)
Condition: Fibrodysplasia Ossificans Progressiva
Intervention:
29 Recruiting Efficacy and Tolerability of BAF312 in Patients With Polymyositis
Condition: Polymyositis
Interventions: Drug: Placebo;   Drug: BAF312
30 Recruiting Abatacept in Juvenile Dermatomyositis
Condition: Dermatomyositis
Intervention: Drug: Abatacept
31 Not yet recruiting Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis
Conditions: Dermatopolymyositis;   Interstitial Lung Disease
Intervention: Drug: Pirfenidone
32 Not yet recruiting A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases
Condition: Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc
Interventions: Biological: MEDI7734;   Biological: Placebo
33 Recruiting Trial of IMO-8400 in Adult Patients With Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: IMO-8400 Dose Group 1;   Drug: IMO-8400 Dose Group 2;   Drug: Placebo
34 Recruiting Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: JBT-101;   Drug: Placebo
35 Not yet recruiting Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders
Conditions: Osteoporosis;   Juvenile Rheumatoid Arthritis;   Dermatomyositis;   Polyarthritis;   Systemic Lupus Erythematosis;   Vasculitis;   Glucocorticoid-induced Osteoporosis
Intervention: Drug: denosumab
36 Recruiting Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study
Condition: Dermatomyositis
Intervention: Drug: Immunoglobulin (Hizentra)
37 Recruiting Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
Conditions: Dermatomyositis;   Juvenile Dermatomyositis
Intervention: Drug: H.P. Acthar Gel
38 Recruiting A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
Condition: Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Intervention: Drug: Prograf
39 Recruiting Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Interventions: Drug: tocilizumab;   Drug: placebo
40 Available Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
Conditions: Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE);   Juvenile Dermatomyositis (JDM);   Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI)
Intervention: Drug: Baricitinib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results    Last Page
Indicates status has not been verified in more than two years